Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
20.03
-0.65 (-3.14%)
At close: Sep 9, 2026, 4:00 PM EDT
20.24
+0.21 (1.05%)
Pre-market: Sep 10, 2026, 7:13 AM EDT
Surrozen Employees
Surrozen had 44 employees as of December 31, 2025. The number of employees increased by 3 or 7.32% compared to the previous year.
Employees
44
Change (1Y)
3
Growth (1Y)
7.32%
Revenue / Employee
$261,614
Profits / Employee
-$7,376,455
Market Cap
235.42M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 44 | 3 | 7.32% | 44 | 0 |
| Dec 31, 2024 | 41 | -1 | -2.38% | 40 | 1 |
| Dec 31, 2023 | 42 | -32 | -43.24% | 42 | 0 |
| Dec 31, 2022 | 74 | -9 | -10.84% | 74 | 0 |
| Dec 31, 2021 | 83 | - | - | 83 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Adagene | 128 |
| Invivyd | 122 |
| Niagen Bioscience | 117 |
| Compugen | 75 |
| Neumora Therapeutics | 63 |
| Eledon Pharmaceuticals | 33 |
| Whitehawk Therapeutics | 32 |
SRZN News
- 1 day ago - Surrozen submits investigational new drug application for SZN-8141 - TheFly
- 2 days ago - Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema - GlobeNewsWire
- 6 days ago - Surrozen Slides: Corporate presentation - Filings
- 7 days ago - Surrozen to Present at Upcoming Healthcare Investor Conferences - GlobeNewsWire
- 21 days ago - Surrozen initiated with an Outperform at William Blair - TheFly
- 4 weeks ago - Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Surrozen Quarterly report: Q2 2026 - Filings
- 5 weeks ago - Surrozen Earnings release: Q2 2026 - Filings